Biovotion, a start-up based in Zurich, has been selected as one of the finalists for the EU SME eHealth Competition at the World of Health IT eHealth week. The competition is to reward the best eHealth solution developed by a European SME.
eHealth Week 2013 brings together two main events: the High Level eHealth Conference co-organised by the European Commission and the Irish Presidency of the Council of the European Union, and WoHIT (World of Health IT Conference & Exhibition) organised by HIMSS Europe. The event not only brings industry partners and providers from across Europe, but also important government and regional decision makers.
The eHealth week 2013 focuses on the continuity of care from the home to hospital and back to home, demonstrating how information can flow between these different care settings. It includes topics such as patients’ empowerment and chronic disease management involving investment and business opportunities in healthcare IT.
Biovotion will present its VSM mHealth solution. The Vital Sign Monitor (VSM) is a wearable multi-sensor platform for continuous, non-invasive monitoring of physiological parameters. Measurements are securely transmitted to a portable device, such as a smartphone, for further processing and transmission into cloud storage. The device can be discretely and comfortably worn on the upper arm during regular activities without the inconveniences associated with the common finger pulse oximeters. It has been demonstrated that the VSM platform provides vital sign data quality on par with standard hospital devices.
Biovotion AG is a Swiss medical device company founded in 2011 and based in Zurich.
Please login or sign up to comment.
Commenting guidelines